Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'gemcitabine' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 668 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Wolff, RA
      Novel therapies for pancreatic cancer

      CANCER JOURNAL
    2. Azuma, A; Matsuda, A; Sasaki, T; Fukushima, M
      1-(3-C-ethynyl-beta-D-ribo-pentofuranosyl)cytosine (ECyd, tas-106)1: Antitumor effect and mechanism of action

      NUCLEOSIDES NUCLEOTIDES & NUCLEIC ACIDS
    3. Harries, M; Kaye, SB
      Recent advances in the treatment of epithelial ovarian cancer

      EXPERT OPINION ON INVESTIGATIONAL DRUGS
    4. Tester, W; Mora, J
      Innovative treatments for advanced non-small cell lung cancer

      EXPERT OPINION ON INVESTIGATIONAL DRUGS
    5. Wadler, S
      New developments in the treatment of ovarian cancer

      EXPERT OPINION ON INVESTIGATIONAL DRUGS
    6. Plosker, GL; Hurst, M
      Paclitaxel - A pharmacoeconomic review of its use in non-small cell lung cancer

      PHARMACOECONOMICS
    7. Tognoni, A; Pensa, F; Vaira, F; Vigani, A; Bancalari, L; Fiasella, L; Maggiani, R; Canessa, P; Pronzato, P
      A three-drug regimen (gemcitabine, ifosfamide and cisplatin) for advanced non-small-cell lung cancer

      JOURNAL OF CHEMOTHERAPY
    8. Nanni, L; Palomba, G; Morelli, F; Piano, A; Simeone, A; D'Alessandro, V; Sirotova, Z; Capuano, G; Rinaldi, B; Lelli, G
      Combination of paclitaxel and etoposide in the treatment of advanced non-small cell lung cancer: A phase I-II study

      JOURNAL OF CHEMOTHERAPY
    9. Evans, DB
      Preoperative chemoradiation for resectable and locally advanced adenocarcinoma of the pancreas

      JOURNAL OF GASTROINTESTINAL SURGERY
    10. Vogelzang, NJ
      Medical oncology update

      UROLOGIC ONCOLOGY
    11. Robinson, BW; Shewach, DS
      Radiosensitization by gemcitabine in p53 wild-type and mutant MCF-7 breastcarcinoma cell lines

      CLINICAL CANCER RESEARCH
    12. Doyle, TH; Mornex, F; McKenna, G
      The clinical implications of gemcitabine radiosensitization

      CLINICAL CANCER RESEARCH
    13. Lawrence, TS; Davis, MA; Hough, A; Rehemtulla, A
      The role of apoptosis in 2 ',2 '-difluoro-2 '-deoxycytidirne (gemcitabine)-mediated radiosensitization

      CLINICAL CANCER RESEARCH
    14. Blackstock, AW; Lightfoot, H; Case, LD; Tepper, JE; Mukherji, SK; Mitchell, BS; Swarts, SG; Hess, SM
      Tumor uptake and elimination of 2 ',2 '-difluoro-2 '-deoxycytidine (gemcitabine) after deoxycytidine kinase gene transfer: Correlation with in vivo tumor response

      CLINICAL CANCER RESEARCH
    15. Ng, SSW; Tsao, MS; Nicklee, T; Hedley, DW
      Wortmannin inhibits PKB/Akt phosphorylation and promotes gemeitabine antitumor activity in orthotopic human pancreatic cancer xenografts in immunodeficient mice

      CLINICAL CANCER RESEARCH
    16. del Pozo, J; Martinez, W; Yebra-Pimentel, MT; Almagro, M; Pena-Penabad, C; Fonseca, E
      Linear immunoglobulin A bullous dermatosis induced by gemcitabine

      ANNALS OF PHARMACOTHERAPY
    17. McGinn, CJ; Lawrence, TS
      Recent advances in the use of radio sensitizing nucleosides

      SEMINARS IN RADIATION ONCOLOGY
    18. Hansen, SW
      Gemcitabine in the treatment of ovarian cancer

      INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
    19. Bookman, MA
      Developmental chemotherapy in advanced ovarian cancer: Incorporation of topoisomerase-I inhibitors and perspective of the Gynecologic Oncology Group

      INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
    20. Saad, SY; Najjar, TAO; Noreddin, AM; Al-Rikabi, AC
      Effects of gemcitabine on cisplatin-induced nephrotoxicity in rats: Schedule-dependent study

      PHARMACOLOGICAL RESEARCH
    21. Nabhan, C; Krett, N; Gandhi, V; Rosen, S
      Gemcitabine in hematologic malignancies

      CURRENT OPINION IN ONCOLOGY
    22. Ianniello, GP; Orditura, M; Rossi, A; De Vita, F; Maiorino, L; Carrozza, F; Manzione, L; Catalano, G
      Gemcitabine plus epirubicin in advanced pancreatic cancer: A phase II multicenter trial

      ONCOLOGY REPORTS
    23. Smid, K; Van Moorsel, CJA; Noordhuis, P; Voorn, DA; Peters, GJ
      Interference of gemcitabine triphosphate with the measurements of deoxynucleotides using an optimized DNA polymerase elongation assay

      INTERNATIONAL JOURNAL OF ONCOLOGY
    24. Brambilla, L; Labianca, R; Ferrucci, SM; Taglioni, M; Boneschi, V
      Treatment of classical Kaposi's sarcoma with gemcitabine

      DERMATOLOGY
    25. Distefano, M; Ferlini, C; De Vincenzo, R; Gaggini, C; Mancuso, S; Scambia, G
      Antagonistic effect of the combination gemcitabine/topotecan in ovarian cancer cells

      ONCOLOGY RESEARCH
    26. Kosmas, C; Tsavaris, N; Panopoulos, C; Vadiaka, M; Stavroyianni, N; Kourelis, T; Malamos, N; Antonopoulos, M; Kalofonos, HP
      Gemcitabine and vinorelbine as second-line therapy in non-small-cell lung cancer after prior treatment with taxane plus platinum-based regimens

      EUROPEAN JOURNAL OF CANCER
    27. Laack, E; Mende, T; Benk, J; Chemaissani, A; Scholtze, J; Lorenz, C; Niestroy, A; Dalhoff, K; Muller, T; Walter, T; Durk, H; Edler, L; Hossfeld, DK
      Gemcitabine and vinorelbine as first-line chemotherapy for advanced non-small cell lung cancer: a phase II trial

      EUROPEAN JOURNAL OF CANCER
    28. Smorenburg, CH; Sparreboom, A; Bontenbal, M; Verweij, J
      Combination chemotherapy of the taxanes and antimetabolites: its use and limitations

      EUROPEAN JOURNAL OF CANCER
    29. Bellmunt, J; de Wit, R; Albanell, J; Baselga, J
      A feasibility study of carboplatin with fixed dose of gemcitabine in 'unfit' patients with advanced bladder cancer

      EUROPEAN JOURNAL OF CANCER
    30. Baron, F; Cueva, J; Grana, B; Curiel, T; Leon, L; Vazquez, F; Candamio, S; Lopez, R
      Gemcitabine plus vinorelbine for the treatment of advanced non-small cell lung cancer

      EUROPEAN JOURNAL OF CANCER
    31. Giaccone, G
      State of the art in systemic treatment of lung cancer

      EUROPEAN JOURNAL OF CANCER
    32. Maurel, J; Zorrilla, M; Puertolas, T; Anton, A; Herrero, A; Artal, A; Alonso, V; Martinez-Trufero, J; Puertas, MD
      Phase I trial of weekly gemcitabine at 3-h infusion in refractory, heavilypretreated advanced solid tumors

      ANTI-CANCER DRUGS
    33. Underhill, CR; Parnis, FX; Highley, MS; Ahern, J; Harper, PG; Hansen, H; Lund, B; Dombernowsky, P; Hirsch, F; Hansen, M; Carmichael, J; Williams, C
      Multicenter phase II study of gemcitabine in previously untreated patientswith advanced epithelial ovarian cancer

      ANTI-CANCER DRUGS
    34. Cassidy, CA; Peterson, P; Cirera, L; Roychowdhury, DF
      Incidence of thrombocytopenia with gemcitabine-based therapy and influenceof dosing and schedule

      ANTI-CANCER DRUGS
    35. Locker, GJ; Wenzel, C; Schmidinger, M; Gnant, MFX; Marosi, C; Jakesz, R; Zielinski, CC; Steger, GG
      Unexpected severe myelotoxicity of gemcitabine in pretreated breast cancerpatients

      ANTI-CANCER DRUGS
    36. Bunn, PA
      State-of-the art treatment of locally advanced and metastatic non-small cell lung cancer

      ANTI-CANCER DRUGS
    37. Crino, L; Cappuzzo, F
      Gemcitabine in the treatment of advanced non-small cell lung cancer: review of main phase II and III trials

      ANTI-CANCER DRUGS
    38. Van Zandwijk, N
      Non-small cell lung cancer neoadjuvant chemotherapy: the benefits of gemcitabine

      ANTI-CANCER DRUGS
    39. Green, MR
      The current status of docetaxel for advanced non-small cell lung cancer

      ANTI-CANCER DRUGS
    40. Jadvar, H; Fischman, AJ
      Evaluation of pancreatic carcinoma with FDG PET

      ABDOMINAL IMAGING
    41. Steer, CB; Marx, GM; Harper, PG
      Is there quality in clinical benefit?

      ANNALS OF ONCOLOGY
    42. Vansteenkiste, JF; Vandebroek, JE; Nackaerts, KL; Weynants, P; Valcke, YJ; Verresen, DA; Devogelaere, RC; Marien, SA; Humblet, YP; Dams, NL
      Clinical-benefit response in advanced non-small-cell lung cancer: A multicentre prospective randomised phase III study of single agent gemcitabine versus cisplatin-vindesine

      ANNALS OF ONCOLOGY
    43. Laufman, LR; Spiridonidis, CH; Pritchard, J; Roach, R; Zangmeister, J; Larrimer, N; Moore, T; Segal, M; Jones, J; Patel, T; Gutterman, L; Carman, L; Colborn, D; Kuebler, JP
      Monthly docetaxel and weekly gemcitabine in metastatic breast cancer: A phase II trial

      ANNALS OF ONCOLOGY
    44. du Bois, A; Luck, HJ; Pfisterer, J; Schroeder, W; Blohmer, JU; Kimmig, R; Moebus, V; Quaas, J
      Second-line carboplatin and gemcitabine in platinum sensitive ovarian cancer - a dose-finding study by the Arbeitsgemeinschaft Gynakologische Onkologie (AGO) Ovarian Cancer Study Group

      ANNALS OF ONCOLOGY
    45. Merimsky, O; Staroselsky, A; Inbar, M; Schwartz, Y; Wigler, N; Mann, A; Marmor, S; Greif, J
      Correlation between c-erbB-4 receptor expression and response to gemcitabine-cisplatin chemotherapy in non-small-cell lung cancer

      ANNALS OF ONCOLOGY
    46. Shannon, C; Crombie, C; Brooks, A; Lau, H; Drummond, M; Gurney, H
      Carboplatin and gemcitabine in metastatic transitional cell carcinoma of the urothelium: Effective treatment of patients with poor prognostic features

      ANNALS OF ONCOLOGY
    47. Vermorken, JB; Zanetta, G; Oliveira, CFD; van der Burg, MEL; Lacave, AJ; Teodorovic, I; Boes, GH; Colombo, N
      Randomized phase III trial of bleomycin, vindesine, mitomycin-C, and cisplatin (BEMP) versus cisplatin (P) in disseminated squamous-cell carcinoma ofthe uterine cervix: An EORTC Gynecological Cancer Cooperative Group study

      ANNALS OF ONCOLOGY
    48. Khuri, FR; Herbst, RS; Fossella, FV
      Emerging therapies in non-small-cell lung cancer

      ANNALS OF ONCOLOGY
    49. Vansteenkiste, J; Gatzemeier, U; Manegold, C; Hanauske, A; Weynants, P; Bosquee, L; Blatter, J; Mansouri, K; von Pawel, J
      Gemcitabine plus etoposide in chemonaive extensive disease small-cell lungcancer: A multi-centre phase II study

      ANNALS OF ONCOLOGY
    50. Alberts, SR; Erlichman, C; Sloan, J; Okuno, SH; Burch, PA; Rubin, J; Pitot, HC; Goldberg, RM; Adjei, AA; Atherton, PJ; Kaufmann, SH
      Phase I trial of gemcitabine and CPT-11 given weekly for four weeks every six weeks

      ANNALS OF ONCOLOGY
    51. Louvet, C; Andre, T; Hammel, P; Selle, F; Landi, B; Cattan, S; Fonck, M; Flesch, M; Colin, P; Balosso, J; Ruszniewski, P; de Gramont, A
      Phase II trial of bimonthly leucovorin, 5-fluorouracil and gemcitabine foradvanced pancreatic adenocarcinoma (FOLFUGEM)

      ANNALS OF ONCOLOGY
    52. Duenas-Gonzalez, A; Lopez-Graniel, C; Gonzalez, A; Reyes, M; Mota, A; Munoz, D; Solorza, G; Hinojosa, LM; Guadarrama, R; Florentino, R; Mohar, A; Melendez, J; Maldonado, V; Chanona, J; Robles, E; De la Garza, J
      A phase II study of gemcitabine and cisplatin combination as induction chemotherapy for untreated locally advanced cervical carcinoma

      ANNALS OF ONCOLOGY
    53. van der Lee, I; Smit, EF; van Putten, JWG; Groen, HJM; Schlosser, NJJ; Postmus, PE; Schramel, FMNH
      Single-agent gemcitabine in patients with resistant small-cell lung cancer

      ANNALS OF ONCOLOGY
    54. Penz, M; Kornek, GV; Raderer, M; Ulrich-Pur, H; Fiebiger, W; Lenauer, A; Depisch, D; Krauss, G; Schneeweiss, B; Scheithauer, W
      Phase II trial of two-weekly gemcitabine in patients with advanced biliarytract cancer

      ANNALS OF ONCOLOGY
    55. De Pas, T; Curigliano, G; Franceschelli, L; Catania, C; Spaggiari, L; de Braud, F
      Gemcitabine-induced systemic capillary leak syndrome

      ANNALS OF ONCOLOGY
    56. Feliu, J; Martin, G; Lizon, J; Chacon, JI; Dorta, J; de Castro, J; Rodriguez, A; Heras, BS; Torrego, JC; Espinosa, E; Baron, MG
      Sequential therapy in advanced non-small-cell lung cancer with weekly paclitaxel followed by cisplatin-gemcitabine-vinorelbine. A phase II study

      ANNALS OF ONCOLOGY
    57. Gallardo, JO; Rubio, B; Fodor, M; Orlandi, L; Yanez, M; Gamargo, C; Ahumada, M
      A phase II study of gemcitabine in gallbladder carcinoma

      ANNALS OF ONCOLOGY
    58. Pectasides, D; Aravantinos, G; Kalofonos, H; Kiamouris, C; Bafaloukos, D; Xiros, N; Nicolaides, C; Visvikis, A; Dimopoulos, MA
      Combination chemotherapy with gemcitabine and ifosfamide as second-line treatment in metastatic urothelial cancer. A phase II trial conducted by the Hellenic Cooperative Oncology Group

      ANNALS OF ONCOLOGY
    59. Spiridonidis, CH; Laufman, LR; Carman, L; Moore, T; Blair, S; Jones, J; George, C; Patel, T; Roach, R; Rupert, R; Zangmeister, J; Colborn, D; Kuebler, JP
      Second-line chemotherapy for non-small-cell lung cancer with monthly docetaxel and weekly gemcitabine: A phase II trial

      ANNALS OF ONCOLOGY
    60. Stathopoulos, GP; Mavroudis, D; Tsavaris, N; Kouroussis, C; Aravantinos, G; Agelaki, S; Kakolyris, S; Rigatos, SK; Karabekios, S; Georgoulias, V
      Treatment of pancreatic cancer with a combination of docetaxel, gemcitabine and granulocyte colony-stimulating factor: A phase II study of the Greek Cooperative Group for Pancreatic Cancer

      ANNALS OF ONCOLOGY
    61. Roila, F; Cortesi, E
      Quality of life as a primary end point in oncology

      ANNALS OF ONCOLOGY
    62. Takechi, T; Koizumi, K; Tsujimoto, H; Fukushima, M
      Screening of differentially expressed genes in 5-fluorouracil-resistant human gastrointestinal tumor cells

      JAPANESE JOURNAL OF CANCER RESEARCH
    63. Miura, S; Yoshimura, Y; Satoh, H; Izuta, S
      The antitumor mechanism of 1-(2-deoxy-2-fluoro-4-thio-beta-D-arabinofuranosyl)-cytosine: Effects of its triphosphate on mammalian DNA polymerases

      JAPANESE JOURNAL OF CANCER RESEARCH
    64. Matsumoto, M; Takeda, Y; Maki, H; Hojo, K; Wada, T; Nishitani, Y; Maekawa, R; Yoshioka, T
      Preclinical in vivo antitumor efficacy of nedaplatin with gemcitabine against human lung cancer

      JAPANESE JOURNAL OF CANCER RESEARCH
    65. Brand, R; Ansari, S; Tarantolo, S
      Pancreatic cancer in the older patient - The Jacobson/Alberts/O'Connell article reviewed

      ONCOLOGY-NEW YORK
    66. Vaughn, DJ; Malkowicz, SB
      Recent developments in chemotherapy for bladder cancer

      ONCOLOGY-NEW YORK
    67. Bunn, PA
      Triplet combination chemotherapy and targeted therapy regimens

      ONCOLOGY-NEW YORK
    68. Curran, WJ; Choy, H
      Optimizing chemoradiation in locally advanced non-small-cell lung cancer

      ONCOLOGY-NEW YORK
    69. Manegold, C
      Treatment of elderly patients with non-small-cell lung cancer

      ONCOLOGY-NEW YORK
    70. Lima, CMSR; Sherman, CA; Brescia, FJ; Brunson, CY; Green, MR
      Irinotecan/gemcitabine combination chemotherapy in pancreatic cancer

      ONCOLOGY-NEW YORK
    71. Georgoulias, VA
      Docetaxel/gemcitabine: Salvage chemotherapy in anthracycline-pretreated patients with advanced breast cancer

      ONCOLOGY-NEW YORK
    72. Conte, P; Salvadori, B; Donati, S; Gennari, A; Cetto, GL; Molino, A; Crino, L; Mazzoni, F; Galligioni, E; Mansutti, M
      The gemcitabine/epirubicin/paclitaxel trials in advanced breast cancer

      ONCOLOGY-NEW YORK
    73. Berlin, JD; Rothenberg, M
      Chemotherapy for resectable and advanced pancreatic cancer

      ONCOLOGY-NEW YORK
    74. Ahlgren, JD
      Chemotherapy for resectable and advanced pancreatic cancer - The Berlin/Rothenberg article reviewed

      ONCOLOGY-NEW YORK
    75. Pettersson, F; Colston, KW; Dalgleish, AG
      Retinoic acid enhances the cytotoxic effects of gemcitabine and cisplatin in pancreatic adenocarcinoma cells

      PANCREAS
    76. Muller, H; Guadagni, S
      Regional plus systemic chemotherapy: an effective treatment in recurrent non-small cell lung cancer

      EUROPEAN JOURNAL OF SURGICAL ONCOLOGY
    77. Rinaldi, D; Lormand, N; Brierre, J; Cole, J; Barnes, B; Fontenot, F; Buller, E; Rainey, J
      A phase I-II trial of topotecan and gemcitabine in patients with previously treated, advanced non-small cell lung cancer (LOA-3)

      CANCER INVESTIGATION
    78. Hainsworth, JD; Burris, HA; Calvert, SW; Willcutt, NT; Scullin, DC; Bramham, J; Greco, FA
      Gemcitabine in the second-line therapy of patients with carcinoma of unknown primary site: A phase II trial of the Minnie Pearl Cancer Research Network

      CANCER INVESTIGATION
    79. Smith, IE; O'Brien, MER; Talbot, DC; Nicolson, MC; Mansi, JL; Hickish, TF; Norton, A; Ashey, S
      Duration of chemotherapy in advanced non-small-cell lung cancer: A randomized trial of three versus six courses of mitomycin, vinblastine, and cisplatin

      JOURNAL OF CLINICAL ONCOLOGY
    80. Bramhall, SR; Rosemurgy, A; Brown, PD; Bowry, C; Buckels, JAC
      Marimastat as first-line therapy for patients with unresectable pancreaticcancer: A randomized trial

      JOURNAL OF CLINICAL ONCOLOGY
    81. Gordon, AN; Fleagle, JT; Guthrie, D; Parkin, DE; Gore, ME; Lacave, AJ
      Recurrent epithelial ovarian carcinoma: A randomized phase III study of pegylated liposomal doxorubicin versus topotecan

      JOURNAL OF CLINICAL ONCOLOGY
    82. Kelly, K; Crowley, J; Bunn, PA; Presant, CA; Grevstad, PK; Mainpour, CM; Ramsey, SD; Wozniak, AJ; Weiss, GR; Moore, DF; Israel, VK; Livingston, RB; Gandara, DR
      Randomized phase III trial of paclitaxel plus carboplatin versus vinorelbine plus cisplatin in the treatment of patients with advanced non-small-celllung cancer: A Southwest Oncology Group trial

      JOURNAL OF CLINICAL ONCOLOGY
    83. Sternberg, CN; de Mulder, PHM; Schornagel, JH; Theodore, C; Fossa, SD; van Oosterom, AT; Witjes, F; Spina, M; van Groeningen, CJ; de Balincourt, C; Collette, L
      Randomized phase III trial of high-dose-intensity methotrexate, vinblastine, doxorubicin, and cisplatin (MVAC) chemotherapy amd recombinant human granulocyte colony-stimulating factor versus classic MVAC in advanced urothelial tract tumors: European organization for research and treatment of cancerprotocol no. 30924

      JOURNAL OF CLINICAL ONCOLOGY
    84. Korn, EL; Arbuck, SG; Pluda, JM; Simon, R; Kaplan, RS; Christian, MC
      Clinical trial designs for cytostatic agents: Are new approaches needed?

      JOURNAL OF CLINICAL ONCOLOGY
    85. Russell, MT; Nassif, AS; Cacayorin, ED; Awwad, E; Perman, W; Dunphy, F
      Gemcitabine-associated posterior reversible encephalopathy syndrome: MR imaging and MR spectroscopy findings

      MAGNETIC RESONANCE IMAGING
    86. Kollmannsberger, C; Mayer, F; Kuczyk, M; Kanz, L; Bokemeyer, C
      Treatment of patients with metastatic germ cell tumors relapsing after high-dose chemotherapy

      WORLD JOURNAL OF UROLOGY
    87. Cohen, EEW; Stadler, WM
      Treatment of metastatic urothelial cancer in the post-MVAC era

      WORLD JOURNAL OF UROLOGY
    88. Lehmann, J; Retz, M; Stockle, M
      The role of adjuvant chemotherapy for locally advanced bladder cancer

      WORLD JOURNAL OF UROLOGY
    89. Casali, M; Marcellini, M; Casali, A; Giuntini, T; Galante, E; Ferrone, C
      Gemcitabine in pre-treated advanced renal carcinoma: a feasibility study

      JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
    90. Chow, KU; Boehrer, S; Geduldig, K; Krapohl, A; Hoelzer, D; Mitrou, PS; Weidmann, E
      In vitro induction of apoptosis of neoplastic cells in low-grade non-Hodgkin's lymphomas using combinations of established cytotoxic drugs with bendamustine

      HAEMATOLOGICA
    91. Allegretto, M; Seikaly, H; Mackey, JR
      Intraoperative saline and gemcitabine irrigation improves tumour control in human squamous cell carcinoma-contaminated surgical wounds

      JOURNAL OF OTOLARYNGOLOGY
    92. Malayeri, R; Pirker, R; Huber, H
      New drugs in the palliative chemotherapy of advanced non-small-cell lung cancer

      ONKOLOGIE
    93. Inoue, A; Saijo, N
      Recent advances in the chemotherapy of non-small cell lung cancer

      JAPANESE JOURNAL OF CLINICAL ONCOLOGY
    94. Okada, S; Ueno, H; Okusaka, T; Ikeda, M; Furuse, J; Maru, Y
      Phase I trial of gemcitabine in patients with advanced pancreatic cancer

      JAPANESE JOURNAL OF CLINICAL ONCOLOGY
    95. Yavuz, AA; Aydin, F; Yavuz, MN; Ilis, E; Ozdemir, F
      Radiation therapy and concurrent fixed dose amifostine with escalating doses of twice-weekly gemcitabine advanced pancreatic cancer

      INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
    96. Pipas, JM; Mitchell, SE; Barth, RJ; Vera-Gimon, R; Rathmann, J; Meyer, LP; Wagman, RS; Lewis, LD; McDonnell, C; Colacchio, TA; Perez, RP
      Phase I study of twice-weekly gemcitabine and concomitant external-beam radiotherapy in patients with adenocarcinoma of the pancreas

      INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
    97. Safran, H; Moore, T; Iannitti, D; Dipetrillo, T; Akerman, P; Cioffi, W; Harrington, D; Quirk, D; Rathore, R; Cruff, D; Vakharia, J; Vora, S; Savarese, D; Wanebo, H
      Paclitaxel and concurrent radiation for locally advanced pancreatic cancer

      INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
    98. Kornek, GV; Potter, R; Selzer, E; Schratter, A; Ulrich-Pur, H; Rogy, M; Kraus, G; Scheithauer, W
      Combined radiochemotherapy of locally advanced unresectable pancreatic adenocarcinoma with mitomycin C plus 24-hour continuous infusional gemcitabine

      INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
    99. Bhargava, P; Marshall, JL; Fried, K; Williams, M; Lefebvre, P; Dahut, W; Hanfelt, J; Gehan, E; Figuera, M; Hawkins, MJ; Rizvi, NA
      Phase I and pharmacokinetic study of two sequences of gemcitabine and docetaxel administered weekly to patients with advanced cancer

      CANCER CHEMOTHERAPY AND PHARMACOLOGY
    100. Edelman, MJ; Quam, H; Mullins, B
      Interactions of gemcitabine, carboplatin and paclitaxel in molecularly defined non-small-cell lung cancer cell lines

      CANCER CHEMOTHERAPY AND PHARMACOLOGY


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 20/10/20 alle ore 22:43:02